GeneDx Holdings (WGS) Gains from Investment Securities (2020 - 2025)
Historic Gains from Investment Securities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $1.2 million.
- GeneDx Holdings' Gains from Investment Securities rose 3159.09% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 6655.0%. This contributed to the annual value of $13.4 million for FY2024, which is 27159.53% up from last year.
- GeneDx Holdings' Gains from Investment Securities amounted to $1.2 million in Q3 2025, which was up 3159.09% from $62000.0 recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Gains from Investment Securities registered a high of $81.7 million during Q3 2021, and its lowest value of -$76.2 million during Q4 2021.
- Its 5-year average for Gains from Investment Securities is -$3.3 million, with a median of $895500.0 in 2023.
- In the last 5 years, GeneDx Holdings' Gains from Investment Securities tumbled by 29794.56% in 2021 and then surged by 29762.44% in 2024.
- Quarter analysis of 5 years shows GeneDx Holdings' Gains from Investment Securities stood at -$76.2 million in 2021, then surged by 79.17% to -$15.9 million in 2022, then surged by 109.23% to $1.5 million in 2023, then skyrocketed by 35.15% to $2.0 million in 2024, then crashed by 41.52% to $1.2 million in 2025.
- Its last three reported values are $1.2 million in Q3 2025, $62000.0 for Q2 2025, and $1.1 million during Q1 2025.